|
PD1-1-1 Phase Ib study of BI 836880 (VEGF/Ang2 nanobody®) plus ezabenlimab (BI 754091, anti-PD-1 antibody) in patients with solid tumors |
|
|
|
Title: |
PD1-1-1 Phase Ib study of BI 836880 (VEGF/Ang2 nanobody®) plus ezabenlimab (BI 754091, anti-PD-1 antibody) in patients with solid tumors |
Author: |
Girard, Nicolas Wermke, Martin Barlesi, Fabrice Kim, Dong-Wan Ghiringhelli, Francois Bennouna, Jaafar Lesimple, Thierry Felip, Enriqueta Berz, David Lee, Jong-Seok Landsteiner, Harald Timotheus Chen, Victoria Jayadeva, Girish Alt, Jurgen Hackanson, Bjorn |
Appeared in: |
Annals of oncology |
Paging: |
Volume 32 () nr. S4 pages S325 |
Year: |
2021 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|